Monthly Investment: Wegovy vs Mounjaro Cost Breakdown
1mg Wegovy Compared to Mounjaro: Understanding Monthly Cost Structures
The monthly cost comparison between 1mg Wegovy and Mounjaro reveals fundamentally different pricing approaches. Wegovy 1mg represents weeks 9-12 of your dose escalation, costing £99.99 monthly at EverydayMeds—a transparent, predictable investment. Mounjaro operates on a different dosing schedule entirely, with 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg options rather than Wegovy's structured 0.25mg-2.4mg escalation. This means direct dose-for-dose comparison isn't clinically meaningful when considering 1mg Wegovy compared to Mounjaro options.
Your monthly budgeting depends significantly on which medication your prescriber recommends based on your individual clinical profile. Wegovy's escalation protocol means you'll progress from 1mg (£99.99) to 1.7mg (£139.99) at week 13, then to maintenance 2.4mg (£209.99) from week 17 onwards. Mounjaro's escalation follows its own timeline, making long-term cost planning essential for either choice. Both medications require ongoing monthly investment as weight management support, not short-term solutions.
Complete UK Pricing Analysis: 1mg Wegovy Compared to Mounjaro Options
EverydayMeds offers comprehensive pricing transparency for your 1mg Wegovy compared to Mounjaro decision-making process. Wegovy 1mg costs £99.99 as a single pen, whilst our Advance Duo bundle (1mg + 1.7mg) costs £269.99 for seamless progression to your next dose level. New customers apply code FIRST40 at checkout, and returning customers use DOSE25 to access these competitive prices. Our GPhC-registered pharmacy (#9012878) ensures you receive authentic medication through proper clinical channels.
Bundle options provide convenience and supply continuity for your ongoing treatment. The Consistency 1mg bundle offers two 1mg pens for £209.99—ideal if your prescriber recommends extending this dose level. Our Progress Trio (0.5mg, 1mg, 1.7mg) costs £369.99, covering three months of structured escalation. These bundles eliminate reordering concerns and ensure uninterrupted treatment, though individual pen purchases offer maximum flexibility for personalised dosing adjustments.
Clinical Evidence: 1mg Wegovy Compared to Mounjaro Mechanisms
Understanding the clinical differences between 1mg Wegovy compared to Mounjaro helps explain their distinct cost structures and treatment protocols. Wegovy contains semaglutide, a GLP-1 receptor agonist that may help reduce appetite and increase feelings of fullness. Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist with a different mechanism of action.
The STEP clinical trials showed that patients taking Wegovy alongside diet and exercise experienced significant weight management benefits (Wilding et al., NEJM, 2021). Mounjaro's clinical programme demonstrated its own efficacy profile through separate trial designs. Both medications require prescription-only access and clinical supervision, making your prescriber consultation essential for determining which option suits your individual circumstances.
How 1mg Wegovy Compared to Mounjaro Works in Your Body
Wegovy's semaglutide acts as a GLP-1 receptor agonist, mimicking a natural hormone that signals fullness to your brain's appetite centres. This mechanism may help reduce food cravings and promote satisfaction with smaller meal portions. Mounjaro's tirzepatide targets both GIP and GLP-1 receptors, potentially offering a different pathway to appetite regulation. Both medications work alongside a reduced-calorie diet and increased physical activity—not as standalone solutions. The 1mg Wegovy dose represents a midpoint in your escalation journey, where many patients begin experiencing more noticeable appetite changes. Your body's response to either medication develops gradually, requiring patience and consistency for optimal results.
Ordering Process: Accessing 1mg Wegovy Compared to Mounjaro Options
EverydayMeds streamlines access to both Wegovy and Mounjaro through our comprehensive online service. Complete our 3-minute clinical assessment covering your medical history, current medications, and weight management goals. Our prescribers review your assessment within 3 working days (24-hour express option available), determining which medication suits your individual profile. Once approved, next-day delivery ensures your prescription-only medicine arrives via temperature-controlled, cold-chain logistics. This process applies whether you're requesting 1mg Wegovy compared to Mounjaro, ensuring proper clinical oversight for either choice. Our GPhC #9012878 registration ensures pharmaceutical compliance and patient safety throughout your treatment journey.
Storage Advantages: 1mg Wegovy Compared to Mounjaro Practical Considerations
Storage requirements significantly impact the practical costs and convenience when comparing 1mg Wegovy to Mounjaro options. Wegovy pens maintain potency for up to 6 weeks at room temperature (below 30°C) once removed from refrigeration, whilst Mounjaro requires refrigeration or room temperature storage for maximum 21 days. This storage advantage makes Wegovy particularly suitable for frequent travellers or those with limited refrigeration access. Both medications use pre-filled pen devices for once-weekly injection, though their specific injection techniques differ slightly. Factor these practical considerations into your monthly cost analysis—medication waste due to storage issues represents false economy. The FlexTouch pen system for Wegovy includes dose confirmation features and ergonomic design for long-term use comfort.
Long-term Budget Planning: 1mg Wegovy Compared to Mounjaro Investment Strategy
Planning your long-term investment in 1mg Wegovy compared to Mounjaro requires understanding each medication's escalation pathway and maintenance costs. Wegovy's structured progression from 1mg (£99.99) leads to 2.4mg maintenance dosing (£209.99 monthly)—approximately £2,520 annually once stabilised. This predictable cost structure enables accurate budgeting for your weight management commitment. Mounjaro's escalation follows different timing and dose levels, requiring separate financial planning considerations.
Consider your maintenance phase investment carefully, as clinical evidence suggests weight management medications work best as long-term treatments rather than short-term interventions. The STEP 1 extension study indicated patients regained approximately two-thirds of lost weight within one year of stopping Wegovy, highlighting the importance of sustained treatment. Factor this ongoing commitment into your 1mg Wegovy compared to Mounjaro decision-making process, ensuring your chosen medication aligns with both your clinical needs and long-term budget capacity.
Expert Recommendation: Making Your 1mg Wegovy Compared to Mounjaro Choice
Both Wegovy and Mounjaro are available through EverydayMeds, and your prescriber can help determine which option best suits your individual circumstances. Consider the monthly cost implications alongside clinical factors—Wegovy's proven escalation protocol and storage advantages versus Mounjaro's dual-mechanism approach and different dosing structure. Your 1mg Wegovy compared to Mounjaro decision impacts not just immediate monthly costs but your entire weight management journey trajectory. Schedule your clinical assessment today using code FIRST40 for new customers or DOSE25 for returning patients, accessing expert guidance on which prescription-only medicine aligns with your goals and budget. Visit https://everydaymeds.co.uk/products/wegovy-1mg to begin your clinically-supervised weight management programme with transparent pricing and pharmaceutical expertise you can trust.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
